Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.

November 25, 2018 11858 Views
Mission Therapeutics (“Mission”), a drug creator company focused on selectively targeting deubiquitylating enzymes (DUBs) and Chicago-based AbbVie (“AbbVie”), ...